Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.20.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2020
Share-based Payment Arrangement [Abstract]  
Activity Related to Incentive Equity Awards
The activity related to the Company’s incentive equity awards for the three months ended March 31, 2020 consisted of the following:
 
RSUs
 
PSUs
 
Number of
RSUs
 
Weighted
Average
Grant Price
 
Number
of
PSUs
 
Weighted
Average
Grant Price
Balance as of December 31, 2019
0.8

 
$
55.75

 
0.1

 
$
52.44

Granted (a)
0.5

 
53.40

 
0.1

 
53.40

Vested
(0.1
)
 
53.14

 

 

Canceled
(0.1
)
 
56.02

 

 

Balance as of March 31, 2020
1.1

(b) 
$
55.02

 
0.2

(c) 
$
52.94

______________________
(a)
Represents awards granted by the Company in February 2020.
(b)
RSUs outstanding as of March 31, 2020 are expected to vest over time and have an aggregate unrecognized compensation expense of $53 million, which is expected to be recognized over a weighted average period of 3.2 years.
(c)
PSUs outstanding as of March 31, 2020 are expected to vest over time and have an aggregate unrecognized compensation expense of $10 million, which may be recognized over a weighted average period of 2.4 years.
The activity related to stock options granted by the Company for the three months ended March 31, 2020 consisted of the following:
 
Number of Options
 
Weighted Average Exercise Price
 
Weighted Average Remaining Contractual Life (Years)
 
Aggregate Intrinsic Value (in millions)
Outstanding as of December 31, 2019
0.9

 
$
56.96

 
 
 
 
Granted
0.6

 
53.40

 
 
 
 
Exercised

 

 
 
 
 
Canceled

 

 
 
 
 
Expired

 

 
 
 
 
Outstanding as of March 31, 2020
1.5

 
$
55.51

 
6.3
 
$

Unvested as of March 31, 2020
1.2

(a) 
$
55.13

 
6.2
 
$

Exercisable as of March 31, 2020
0.3

 
$
57.15

 
6.4
 
$

______________________
(a)
Unvested options as of March 31, 2020 are expected to vest over time and have an aggregate unrecognized compensation expense of $11 million, which is expected to be recognized over a weighted average period of 3.2 years.
Schedule of Valuation Assumptions
 
2020
 
2019
Grant date fair value
$8.59
 
$10.46
Grant date strike price
$53.40
 
$52.44
Expected volatility
24.30%
 
22.24%
Expected life
4.25 years
 
6.25 years
Risk-free interest rate
1.21%
 
2.63%
Projected dividend yield
2.40%
 
2.21%